Cole Batty, PhD – Dana-Farber Cancer Institute, Marasco Laboratory
Hanwen Melvin Lye, MBA, BCMAS – Senior Director, Scientific Affairs, Curiox Biosystems
This technical note provides an analysis of how manual preparation impacts reproducibility, QC repeats, and reagent use in complex antibody panels. Gain a data-driven decision framework and cost model for when automation truly pays off in your workflow.
✓ Quantifies when automation becomes cost-effective based on hands-on time and batch size
✓ Explains how increasing panel complexity amplifies preparation variability and repeat exposure
✓ How manual preparation variability and human pipetting error drive repeat runs and how automation reduces re-run frequency.
12-15 min read • Immediate access
